0001178913-19-001740.txt : 20190620 0001178913-19-001740.hdr.sgml : 20190620 20190620073728 ACCESSION NUMBER: 0001178913-19-001740 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190620 DATE AS OF CHANGE: 20190620 EFFECTIVENESS DATE: 20190620 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPHERA FUNDS MANAGEMENT LTD. CENTRAL INDEX KEY: 0001496201 IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: 1934 Act SEC FILE NUMBER: 028-15863 FILM NUMBER: 19907468 BUSINESS ADDRESS: STREET 1: 21 HA'ARBA'AH STREET CITY: TEL AVIV STATE: L3 ZIP: 64739 BUSINESS PHONE: 972-3-6845535 MAIL ADDRESS: STREET 1: 21 HA'ARBA'AH STREET CITY: TEL AVIV STATE: L3 ZIP: 64739 13F-HR/A 1 primary_doc.xml 13F-HR/A LIVE false false false 0001496201 XXXXXXXX 03-31-2019 03-31-2019 true 1 NEW HOLDINGS false SPHERA FUNDS MANAGEMENT LTD.

21 HA'ARBA'AH STREET Tel Aviv L3 64739

13F HOLDINGS REPORT 028-15863 Y This Form 13F/A is filed as an amendment to the Form 13F filed on May 7, 2019 (the "Original 13F Q1/2019 Filing"), to add new holdings entries which were unintentionally omitted from the Original Q1/2019 13F Filing, which otherwise remains unchanged. Investment discretion with regard to a portion of the securities reported herein is exercised by Sphera Global Healthcare Management L.P. (the "Management Company"). The Management Company is managed, controlled, and operated by its general partner, Sphera Global Healthcare GP Ltd. (the "General Partner"), the shares of which are owned 50% by Sphera Funds Management Ltd. ("SFML"). SFML is entitled to appoint 50% of the members of the board of directors of the General Partner (the "Board of Directors") and 50% of the members to the investment committee of the Management Company (the "Investment Committee"), and therefore may be deemed to share control of the General Partner and Management Company. This Form 13F shall not be construed as an admission by SFML, the General Partner, or the Management Company that it is the beneficial owner of any of the securities covered by this Form 13F, and each of SFML, the General Partner, and the Management Company disclaim beneficial ownership of any such securities. Per informal guidance received from the Division of Investment Management, section 13(f) securities that are dual listed on a U.S. stock exchange and the Tel Aviv Stock Exchange were included in this Form 13F only if they were purchased in the U.S. Israel Mor 972-3-6845535 /s/ Israel Mor Tel Aviv L3 06-20-2019 2 2 7172 1 0001599855 028-15864 Sphera Global Healthcare GP Ltd. 2 0001599854 028-15865 Sphera Global Healthcare Management LP INFORMATION TABLE 2 infotable.xml HARPOON THERAPEUTICS INC COM 41358P106 3133 330800 SH DFND 1,2 330800 0 0 PRECISION BIOSCIENCES INC COM 74019P108 4039 225000 SH DFND 1,2 225000 0 0